Antitumor efficacy and toxicity of methyltrienolone (NSC-92858) in advanced breast cancer.
D000005:Abdomen / Q000187:drug effects; D045930:Anabolic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005221:Fatigue / Q000139:chemically induced; D005260:Female; D005500:Follow-Up Studies; D006628:Hirsutism / Q000139:chemically induced; D006801:Humans; D009325:Nausea / Q000139:chemically induced; D013035:Spasm / Q000139:chemically induced; D013448:Sulfobromophthalein / Q000378:metabolism
D045930:Anabolic Agents; D000970:Antineoplastic Agents; D013448:Sulfobromophthalein; D001219:Aspartate Aminotransferases